Universe Pharmaceuticals Files 6-K for August 2024 AGM

Ticker: UPC · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1809616

Universe Pharmaceuticals INC 6-K Filing Summary
FieldDetail
CompanyUniverse Pharmaceuticals INC (UPC)
Form Type6-K
Filed DateSep 3, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting, foreign-private-issuer

TL;DR

Universe Pharma filed a 6-K for August, shareholders meeting coming up.

AI Summary

Universe Pharmaceuticals INC filed a Form 6-K on September 3, 2024, for the month of August 2024. The filing is related to the company's 2024 Annual General Meeting of Shareholders. Universe Pharmaceuticals INC is incorporated under the laws of the Cayman Islands and its principal executive offices are located in Ji'an, Jiangxi, China.

Why It Matters

This filing provides an update on corporate governance matters, specifically related to the upcoming Annual General Meeting of Shareholders, which is important for investor oversight and company direction.

Risk Assessment

Risk Level: low — This is a routine filing related to an upcoming shareholder meeting and does not contain new financial or operational information that would typically increase risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of August 2024, in connection with the 2024 Annual General Meeting of Shareholders.

When was this report filed?

This report was filed on September 3, 2024.

Under which laws is Universe Pharmaceuticals INC incorporated?

Universe Pharmaceuticals INC is incorporated under the laws of the Cayman Islands.

What is the business address of Universe Pharmaceuticals INC?

The business address is 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China, 343100.

Does Universe Pharmaceuticals INC file annual reports under Form 20-F or 40-F?

Universe Pharmaceuticals INC files annual reports under Form 20-F.

Filing Stats: 257 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-09-03 16:10:23

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   Universe Pharmaceuticals INC. Date: September 3, 2024   By:   /s/ Gang Lai         Gang Lai         Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing